复方861对大鼠肝星状细胞增殖及胶原合成的影响1

中国临床药理学与治疗学 ›› 1998, Vol. 3 ›› Issue (3): 172-174.

复方861对大鼠肝星状细胞增殖及胶原合成的影响¹

马红, 王宝恩, 马雪梅, 贾继东

北京友谊医院肝病研究中心, 北京100050

收稿日期:1998-07-27 发布日期:2020-12-02
作者简介:马红, 女, 30 岁, 内科学博士, 主治医师, 主要从事慢性肝病肝纤维化方面的研究。王宝恩, 男, 72 岁, 教授, 主任医师, 博士生导师, 中华医学会肝病学会名誉主任委员、北京分会主任委员, 主要从事消化内科与急救医学方面的研究。
基金资助:
1 国家中医药管理局资助课题

Effect of compound 861 on hepatic stellate cell poroliferation and collagen synthesis

MA Hong, WANG Bao-En, MA Xue-Mei, JIA Ji-Dong

Liver Research Center Beijing Friendship Hospital, Beijing 100050

Received:1998-07-27 Published:2020-12-02

摘要/Abstract

摘要： 目的观察中药复方861对体外培养肝星状细胞增殖及胶原合成的影响。方法分离培养大鼠肝星状细胞, 传一代后加入不同浓度的复方861 作用48 小时, 以MT T 比色法检测对细胞增殖的作用。传一代细胞以10 mg/ml复方861作用48小时后, 以ELISA法、斑点杂交法检测胶原蛋白分泌及相应mRNA 水平的变化。结果 1.56~100 mg/ml 复方861(经0.45 μm 滤膜过滤)可使MTT转化率下降, 细胞增殖受抑, 呈明显的剂量依赖性;10 mg/ml 复方861 可使I 、III 、IV 型胶原及转化生长因子β1(TGFβ1)mRNA 水平及相应蛋白分泌量下降。结论复方861 抗纤维化的部分机理在于抑制活化肝星状细胞的增殖及胶原蛋白的合成, 从而减少胶原纤维在肝脏内的沉积。

关键词: 肝星状细胞, 细胞培养, 细胞外基质

Abstract: Aim The effect of compound 861 (Cpd 861) on rat hepatic stellate cell(HSC) proliferation and collagen synthesis in vitro was observed. Methods The second passage of HSC was exposed to Cpd 861 at a concentration of 1.56 ~ 100 mg/ ml for 48 hours. MTT colorimetric assay was used to evaluate the effect of Cpd 861 on HSC proliferation. After incubation with Cpd 861 for 48 hours, HSC was harvested to determine collagen type I, III, IV mRNA by dot blot hybridization and cell culture medium was used to detect collagen secretion by ELISA method. Results Cpd 861 (through 0.45 μm filter membrane) could reduce MTT transforming rate and the inhibitory effect had a positive relation with the concentration of Cpd 861 in the cultured medium. Type I, III, IV collagen and TGF(β1 productions, were inhibited by Cpd 861 at a concentration of 10 mg/ml. Conclusion The antifibrotic mechanism of Cpd 861 was partly due to its inhibition of HSC proliferation and collagen production, which would reduce deposition in the liver.

Key words: hepatic stellate cell, cell culture, extracellular matrix, herbal compound

中图分类号:

R575.2

马红, 王宝恩, 马雪梅, 贾继东. 复方861对大鼠肝星状细胞增殖及胶原合成的影响¹[J]. 中国临床药理学与治疗学, 1998, 3(3): 172-174.

MA Hong, WANG Bao-En, MA Xue-Mei, JIA Ji-Dong. Effect of compound 861 on hepatic stellate cell poroliferation and collagen synthesis[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(3): 172-174.

参考文献

1 Wang BE, Jia JD. Treatment of liver fibrosis. In: Lam SK, Pamgarner G, Wang BE (eds).Update on Hepatobiliary Diseases. Klumer Academic Publisher. London, 1996: 193
2 陈原稼, 王宝恩, 马雪梅, 等.大鼠贮脂细胞的分离及培养.肝脏病杂志, 1993; 1: 17
3 陈非, 邓鸿业, 邓玉兰, 等. MTT法分析肺泡MΦ上清促纤维母细胞生长活性. 免疫学杂志,1993; 9: 127
4 Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat storing cells but not in hepatocytes, 1990; 12: 511
5 刘妙良. 地高辛配基标记核酸技术及其应用. 生物化学与生物物理学进展, 1992; 19: 34
6 Chomczyzski P, Sacchi N. Single step method of RNA isolation by acid guanidunium thiocyanate-phenol chloroform extraction. Anal Biochem, 1990; 188: 245
7 Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis, 1990; 10: 20
8 Gressner AM. Molecular mechanism of liver fibroge-nesis. —a homage to the role of activated fat-toring cells. Digestion, 1995; 56: 335
9 Friedman SL, Roll J, Boyles J, et al. M aintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem, 1989; 264: 10756
10 Knittel T, Janneck T, Muller L, et al. Transforming growth factor β1-regulated gene expression of Ito cells. Hepatology, 1996; 24: 352
11 Win KM, Charlotte F, Mallat A, et al. Mitogenic effect of transforming growth factor-β1 on human I to cells in culture: Evidence for mediation by endogenous platelet derived growth factor. Hepatology, 1993; 18: 137
12 Pinzani M, Gentilini A, Caligiuri A, et al. Trans forming growth factor-β1 regulates regulates platelet derived receptor β subunit in human liver fat-storing cells. Hepatology, 1995; 21: 232
13 Bachem MG, Meyer D, Schafer W, et al. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with there transdifferentiation into myofibroblast-like cells in culture. J Hepatol, 1993; 18: 40

[1]	田大皓, 卢林明, 支慧, 周珏, 王晓庆, 江玉华. 皖南蝮蛇毒抑瘤组分-Ⅰ对人原代胃癌细胞增殖的影响[J]. 中国临床药理学与治疗学, 2020, 25(5): 505-511.
[2]	谢加力，李俊. 内质网应激通过C/EBP同源蛋白调控死亡受体5对肝星状细胞凋亡的影响[J]. 中国临床药理学与治疗学, 2020, 25(2): 159-166.
[3]	陈佳，刘青武，何秀娟，李萍. 细胞外基质在皮肤创面修复中的研究进展[J]. 中国临床药理学与治疗学, 2019, 24(6): 716-720.
[4]	何阳，宋立莹，彭向东，方伟进，王春江，邓珍珍，樊志强，刘世坤. 发酵虫草菌粉对DEN致大鼠肝损伤的保护作用及TGF-β1/Smads通路的影响[J]. 中国临床药理学与治疗学, 2018, 23(9): 974-982.
[5]	曹媛，夏延哲，陈杰，陈孝. 五味子甲素在人肝星状细胞中的抗纤维化作用[J]. 中国临床药理学与治疗学, 2016, 21(8): 878-883.
[6]	周露萍, 陈露露, 周宏灏, 欧阳冬生. IV型胶原蛋白与肾脏疾病[J]. 中国临床药理学与治疗学, 2015, 20(9): 1060-1065.
[7]	章圣朋, 刘晓平, 沈杰, 谢加力. 夏枯草总三萜对乙醛刺激的肝星状细胞作用及部分机制[J]. 中国临床药理学与治疗学, 2015, 20(4): 404-408.
[8]	潘春晓, 唐杰, 王晓宇, 王雯, 刘甲莉, 吴繁荣, 陈飞虎. 酸敏感离子通道1a在酸诱导的大鼠肝星状细胞活化中的作用[J]. 中国临床药理学与治疗学, 2014, 19(5): 528-533.
[9]	宋立莹, 彭向东, 王春江, 郭韧, 刘世坤. miRNA参与肝星状细胞活化及慢性肝病发展的作用机制研究进展[J]. 中国临床药理学与治疗学, 2014, 19(12): 1422-1428.
[10]	孙永, 黄小华, 沈能, 唐华东, 任红, 彭明利. 姜黄素衍生物对原代大鼠肝星状细胞作用的体外研究[J]. 中国临床药理学与治疗学, 2014, 19(10): 1086-1092.
[11]	朱艳虹, 陈真, 钱之玉, 成文媛, 胡慧. 西红花酸对乙醛诱导的肝星状细胞增殖和胶原合成的影响[J]. 中国临床药理学与治疗学, 2013, 18(8): 841-846.
[12]	成志云, 彭俊纯, 吕颖慧. 上皮-间充质转化对肝纤维化作用的研究进展[J]. 中国临床药理学与治疗学, 2013, 18(8): 928-936.
[13]	陈杰, 李瑞明, 许静, 官碧琼, 罗子玲. 蟛蜞菊内酯对脂多糖诱导RAW264.7细胞环氧化酶2、NO及TNF-α的影响[J]. 中国临床药理学与治疗学, 2012, 17(2): 171-174.
[14]	王志勇, 吴俊华, 王玉蓉, 余德才, 丁义涛. 鸢尾黄素对肝星状细胞外基质表达的影响[J]. 中国临床药理学与治疗学, 2012, 17(2): 175-180.
[15]	陈猛, 马勇. 哌唑嗪和去氧肾上腺素对大鼠肝星状细胞增殖和凋亡的作用[J]. 中国临床药理学与治疗学, 2011, 16(9): 981-985.

复方861对大鼠肝星状细胞增殖及胶原合成的影响¹

Effect of compound 861 on hepatic stellate cell poroliferation and collagen synthesis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价